Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tradr 2X Short TSLA Daily ETF
TSLQ
5
ProShares UltraPro Short S&P500 ETF
SPXU
US Stock MarketDetailed Quotes
ALEC Alector
- 1.130
- -0.030-2.59%
Close Apr 29 16:00 ET
112.99MMarket Cap-0.92P/E (TTM)
1.180High1.120Low373.01KVolume1.170Open1.160Pre Close425.86KTurnover0.50%Turnover RatioLossP/E (Static)99.99MShares6.78052wk High0.89P/B83.89MFloat Cap0.87052wk Low--Dividend TTM74.24MShs Float43.320Historical High--Div YieldTTM5.17%Amplitude0.870Historical Low1.141Avg Price1Lot Size
About Alector Company
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.
Company Profile
SymbolALEC
Company NameAlector
Listing DateFeb 7, 2019
Issue Price19.00
Founded2013
CEODr. Arnon Rosenthal, PhD
MarketNASDAQ
Employees244
Fiscal Year Ends12-31
Address131 Oyster Point Boulevard,Suite 600
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080-2029
Phone1-415-231-5660
Websitehttp://www.alector.com
Company Executives
- Name
- Position
- Salary
- Dr. Arnon Rosenthal, PhD
- Director and Chief Executive Officer
- 3.67M
- Dr. Marc Grasso, M.D.
- Chief Financial Officer and Principal Accounting Officer
- 1.69M
- Louis J. Lavigne, Jr
- Chairman of the Board
- 257.00K
- Dr. Saraswati Kenkare-Mitra, PhD
- President and Head, Research and Development
- 2.55M
- Dr. Richard H. Scheller, PhD
- Director
- 403.18K
- Mark Altmeyer
- Independent Director
- 389.09K
- David M. Wehner
- Independent Director
- 229.50K
- Dr. Paula Hammond, PhD
- Independent Director
- 222.00K
- Dr. Kristine Yaffe, M.D.
- Independent Director
- 219.50K
- Dr. Errol B. De Souza,PhD
- Independent Director
- 391.05K
- Dr. Elizabeth A. Garofalo, M.D.
- Independent Director
- 224.50K
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now